Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 231 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2784 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RASAGILINE | 1MG | TABLET | Resolved | 2023-11-17 | 2023-12-08 | 210743 |
| APO-PRUCALOPRIDE | 1MG | TABLET | Resolved | 2024-02-16 | 2024-03-29 | 219834 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-05 | 2024-05-15 | 224589 |
| APO-ANASTROZOLE | 1MG | TABLET | Anticipated shortage | 2024-04-12 | 2024-04-12 | 225101 |
| APO-VARENICLINE | 1MG | TABLET | Actual shortage | 2024-04-19 | 2024-05-17 | 225764 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-19 | 2024-05-15 | 225782 |
| APO-REPAGLINIDE | 2.0MG | TABLET | Resolved | 2017-03-11 | 2018-09-11 | 481 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2017-06-28 | 2017-11-30 | 14219 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2019-12-12 | 2020-03-27 | 101097 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2020-10-14 | 2020-11-09 | 126317 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2021-02-19 | 2021-04-05 | 134442 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2021-06-04 | 2021-06-21 | 140428 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-05-19 | 2023-08-04 | 192803 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-05-19 | 2023-08-04 | 192821 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-09-22 | 2023-12-01 | 205002 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-12-22 | 2024-05-03 | 214247 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2024-03-01 | 2024-04-26 | 221090 |
| APO-PERINDOPRIL/AMLODIPINE | 2.5MG 3.5MG | TABLET | Resolved | 2023-12-01 | 2023-12-15 | 212386 |
| APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2017-03-17 | 2017-07-20 | 3169 |
| APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2017-03-21 | 2017-04-14 | 3800 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
| APO-CYCLOBENZAPRINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60405 |
| APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60443 |
| APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60447 |
| APO-ENALAPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-12-05 | 60462 |
| APO-ESCITALOPRAM | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-11-16 | 60474 |
| APO-LISINOPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
| APO-MEMANTINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60615 |
| APO-OXAZEPAM | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-08-30 | 60675 |
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-07-13 | 60758 |
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |
| APO-SIMVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60790 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
| APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
| APO-PINDOL TAB 10MG | 10MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154571 |
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-11-19 | 2018-11-19 | 67146 |